The overexpression of either CAB39L or SESN1 mimicked the effect of metformin, while the depletion of CAB39L or SESN1 increased both clonogenicity and migration of all the breast cancer cell lines tested (Figure 4a–f, Supplementary Figure S4a–d). This evidence concerns the gene SESN1 and breast carcinoma.